Individuals with ulcerative colitis (UC) appear to be at an elevated risk of developing and dying from colorectal cancer (CRC), despite often presenting at an earlier stage of CRC than those without UC, a recent study showed.
The adalimumab biosimilar BI 695501 shows similar efficacy and safety profile as its reference product in patients with moderate-to-severe Crohn's disease (CD), according to a phase III study recently presented at the Advances in Inflammatory Bowel Diseases (AIBD) 2019 Conference.
Metabolic and bariatric surgery (MBS) decreases the prevalence of musculoskeletal and lower extremity (LE) joint pain and poor physical function in severely obese adolescents, according to the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS*) study.
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
Antibiotic resistance of Helicobacter (H.) pylori has more than doubled in Europe in the past two decades, raising alarm on the gravity of the issue of growing bacterial resistance to commonly-used antibiotics, a study presented at UEG Week 2019 has shown.
Supplementation with oral drops containing the probiotic Bifidobacterium animalis subsp. lactis BB‐12 (BB‐12) effectively reduces crying time in infants with colic, suggesting that the gut microbiota can be a target of intervention for infant colic, a study shows.
Symptomatic gastroesophageal reflux disease (GERD) is associated with chronic, painful temporomandibular disorder (TMD), with somatization, anxiety, and poor sleep influencing this association to a certain extent, a case-control study has shown.
Faecal microbiota transplantation (FMT) is effective in reducing symptoms of irritable bowel syndrome (IBS), but having a “super-donor” is key, a study presented at UEG* Week has shown — highlighting the importance of donor selection for the success of FMT as a treatment for IBS.
Whether perioperative chemotherapy incorporating S-1 in the neoadjuvant setting provides better treatment outcomes than adjuvant chemotherapy postoperatively for patients with locally advanced gastric cancer (LAGC) was the topic of a lively discussion during the lunch forum session at the ISSPP 2019 Congress.
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
Anaemia increases mortality risk in heart failure (HF) patients across the ejection fraction (EF) spectrum, a recent study has found. The effect appears to be stronger in preserved (HFpEF) and midrange (HFmrEF) than in reduced (HFrEF) EF disease.